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Abstract
Objective—Psychiatric advance directives (PADs) allow individuals to plan for future mental
health treatment. However, little is known about barriers to PAD completion. This paper examines
an intervention's effect in reducing barriers to PAD completion.
Method—Patients were randomly assigned to a facilitated PAD session or control group. Barriers
associated with (1) the PAD documents and (2) external support for PADs were assessed at
baseline (N=462), six months (N=380) and one year (N=362).
Results—There were no significant baseline between-group differences on the two barriers.
However, at follow-up both barriers were significantly lower in the experimental group. Further,
barriers were predictive of PAD completion.
Conclusions—Structured facilitation can significantly reduce barriers to PAD completion.
However, the intervention did not eliminate barriers. Findings are discussed in the context of
possible system-level changes to further reduce barriers to PAD completion.
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Recent research has begun to describe the applied benefits associated with completing
psychiatric advance directives (PADs). This research has moved beyond demonstrating a
large latent demand for PADs (Swanson, Swartz, Ferron, Elbogen, & Van Dorn, 2006b) to
indicating that interventions designed to facilitate completion of PADs can improve
treatment satisfaction, working alliance and competence to make treatment decisions
(Elbogen, Swanson, Appelbaum, Swartz, Ferron, Van Dorn, & Wagner, 2007; Swanson,
Swartz, Elbogen, Van Dorn, Ferron, Wagner, McCauley, & Kim, 2006a). Evidence also
indicates that completed PADs evince strong clinical utility, including appropriate and
useful references to available services and treatments (Srebnik, Rutherford, Peto, Russo,
Zick, Jaffe, & Holtzheimer, 2005).
However, research suggests that while a majority of consumers with severe mental illness
would desire PADs, a very small proportion has actually completed them (Swanson et al.,
2006b). A recent randomized trial demonstrated that a structured facilitation can
dramatically increase PAD completion rates (Swanson et al., 2006a). Results from this study
indicated that 61% of participants in the facilitated session completed an advance directive
or authorized a proxy decision maker, compared with only 3% of control group participants.
The current paper builds on these core findings and attempts to answer questions related to
(1) specific types of barriers preventing PAD completion, (2) whether perceived barriers
predict PAD completion and if so, (3) how to effectively reduce these barriers. Broadly, the
question remains: if structured facilitation enables people with severe mental illness to
complete PADs, how does it work and, how can facilitations be improved to allow more
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persons with mental illness to successfully complete PADs? The current study examined a
structured intervention's effect in reducing specific barriers to the completion of PADs over
the course of one year.
Background on Psychiatric Advance Directives
Psychiatric advance directives are legal documents that allow patients to consent to or refuse
future mental health treatment in the event of an incapacitating psychiatric crisis through the
documentation of advance instructions and/or appointment of a surrogate decision maker
(Srebnik & La Fond, 1999). Consumers' and consumer advocacy groups' demand for and
interest in PADs have resulted in legislation in 25 states wherein PADs have either been
authorized in new statutes or by revisions to existing health care decisions laws. The
initiation of a MacArthur Foundation-funded national resource center on psychiatric
advance directives (see nrc-pad.org) is further evidence of increasing interest in PADs.
Despite this recent legislative action, many questions remain unanswered regarding certain
aspects of PADs, including the need and ability to reduce perceived barriers to completion,
particularly factors associated with the PAD documents themselves and external support for
PADs.
Barriers and Psychiatric Advance Directives
The discrepancy between consumers' demand for PADs and their actual completion of these
legal documents may be due to the varied and substantial barriers to PADs facing both
consumers of mental health services and the systems that treat them (Swanson et al., 2006a;
Van Dorn, Swartz, Elbogen, Swanson, Kim, Ferron, McDaniel, & Scheyett, 2006b). On the
one hand, clinicians report barriers related to the operational features of the work
environment, including a lack of communication between staff and lack of access to the
document. Clinicians also describe barriers related to clinical or treatment factors, including
consumers' inappropriate treatment requests and desires to change their mind about
treatment during crises (Van Dorn et al., 2006b). It is possible that these barriers have
prevented clinicians from fully supporting consumers' completion of PADs. On the other
hand, consumers report barriers related to difficulty in understanding PADs, skepticism
about their benefit and lack of contact with a trusted individual who could serve as proxy
decisionmaker, or simply not having a clinician to trust (Swanson, Swartz, Hannon,
Elbogen, Wagner, McCauley, & Butterfield, 2003).
Conceptual Framework
This study assesses change in consumers' perceived barriers to PAD completion in a 1-year
randomized trial of an intervention to facilitate PAD completion by persons with severe
mental illness. (For information on the parent study, see Swanson et al., 2006a.) This study
addresses the following four questions: (1) Are perceived barriers related to PAD documents
themselves and external support for PADs reduced over time for the experimental group
compared to the control group? (2) What characteristics of consumers are associated with
reduced barriers? (3) What is the PAD completion rate for those whose barriers were
reduced over time compared to those whose barriers increased over time? (4) Do perceived
barriers predict PAD completion? These questions are grounded in a conceptual framework
that includes relevant demographic, clinical and social factors that draw on prior research
findings regarding demand for (Srebnik, Russo, Sage, Peto, & Zick, 2003; Swanson et al.,
2006b) and completion of and outcomes associated with PADs (Elbogen et al., 2007;
Srebnik, Appelbaum, & Russo, 2004; Swanson et al., 2006a).
Van Dorn et al. Page 2














A total of 469 patients with severe mental illness were randomly assigned to a facilitated
psychiatric advance directive session or a control group that received written information
about psychiatric advance directives and referral to resources in the public mental health
system. Perceived barriers to PAD completion were assessed at baseline, one, six and twelve
months.
Sample selection
The study's sample criteria included: (1) age 18–65; (2) chart diagnosis of schizophrenia,
major mood disorder with psychotic features, or bipolar disorder; (3) currently receiving
community-based treatment provided through one of two county-based programs in the
north-central region of North Carolina; and (4) able to give informed consent to the study.
The Facilitated Psychiatric Advance Directive (F-PAD) Intervention
The F-PAD is a semi-structured, manualized interview and guided discussion of choices
involved in anticipatory mental health treatment planning. The F-PAD is adapted from
several medical and psychiatric advance directive planning tools (California Protection and
Advocacy, 2003; Colvin & Hammes, 1991; Hammes & Rooney, 1998) while incorporating
the required statutory elements of PADs specific to the state of North Carolina.
The intervention was conducted by five trained research assistants, one with a master's
degree and the others with bachelor's degrees. They were trained to fidelity by a doctoral-
level clinical psychologist until they consistently achieved a score of at least 87% on 15
fidelity criteria. Reliability and fidelity were then monitored by random observation and
fidelity measurement, with remediation as needed.
The intervention included orientation to PAD concepts, review of past treatment
experiences, and documentation of future treatment preferences. If the participant wished to
prepare the relevant legal PAD documents, the facilitator provided assistance with
completing these forms. The specific sections of the advance instruction and health care
power of attorney statutory forms (e.g., including medication choices, facilities preferences,
powers granted to, or withheld from, the health care agent) are used to organize and guide
discussion of the participant's preferences. The facilitator also assisted the participant in
obtaining witnesses, notarization, and filing forms in the medical record and an electronic
registry. The intervention also allowed the facilitator to contact, with participants' consent,
potential HCAs to explain the process and answer any questions they had about what to do
during a crisis.
Control group
Participants in the control group were given an introduction to PADs, written materials
describing the purpose of PADs, copies of standard PAD forms, and the toll-free telephone
number of the local consumer organization that provides consultation to persons who wish
to prepare PADs. Participants with poor literacy skills had the materials read to them aloud.
However, control group participants were not assisted with contacting the local consumer
organization nor were they given aid in filling out PAD forms.
Screening, informed consent, recruitment and randomization
A random sample was drawn from de-identified lists of mental health program clients pre-
screened for eligibility. Sequential admissions from the programs to the regional state
psychiatric hospital were also screened. Following informed consent and baseline interview,
each participant was randomized to the F-PAD intervention or control group. A soon as
Van Dorn et al. Page 3













possible following the baseline interview, a separate session to conduct the F-PAD was
scheduled with participants who were randomized to the experimental group. The study
protocol was approved by the Duke University Medical Center Institutional Review Board
(IRB) and by the IRBs of the participating programs and hospital.
Measures
PAD barriers
Participants were asked to rate their perceptions of barriers to the completion of PADs. The
four barriers assessed were: (1) not understanding the document(s); (2) not knowing what to
say or write in the document(s); (3) having no one trustworthy to make decisions or naming
someone for the HCA; (4) having no clinician to trust or an inability to get information from
one's clinician about what to include in the PAD.
Identification of these PAD barriers is based on our prior work, including feedback from
prior stakeholder surveys that examined factors associated with PADs (cf., Swanson et al.,
2003). Our intent in specifying these four barriers was to tap into two potential
conceptualizations of barriers faced by consumers, specifically “barriers associated with the
PAD documents themselves” (i.e., not understanding the document and not knowing what to
say or write in the document) and “barriers associated with external support for PADs” (i.e.,
having no one trustworthy to make decisions and not having a clinician to trust). This
conceptualization of barriers is theoretically consistent with our prior research on clinicians'
perceptions of barriers to PAD implementation (Van Dorn et al., 2006b) where clinicians
identified barriers related to the PAD documents and systemic barriers external to the PAD
documents. For the current analyses, barriers ranged between zero and two for each of the
two barriers and were assessed at baseline, one, six and twelve months.
Covariates
Five time-variant covariates, which were assessed at the three study time points, were
included in all multivariable models. Working alliance was assessed with the short form of
the Working Alliance Inventory (WAI) adapted for use with SMI individuals (Horvath &
Greenberg, 1989; Neale & Rosenheck, 1989). Satisfaction with mental heath services was
measured by utilizing several items from the Mental Health Statistics Improvement Program
(MHSIP) Consumer Survey Index of Treatment Satisfaction (Ganju, 1999). Some
participants who were interviewed could not answer the questions regarding mental health
services or working alliance with a clinician, because they had not received services recently
enough, and did not have enough contact with a clinician, to be able to rate these items. In
these cases, items with missing values on the two measures were imputed as neutral scores
(Swanson et al., 2006a). The number of monthly outpatient mental health visits was also
included in multivariable models, with those having more than one visit compared to those
with one or zero visits. The anchored version of the Brief Psychiatric Rating Scale (BPRS)
was used to assess current psychiatric symptoms (Woerner, Mannuzza, & Kane, 1988).
Finally, a single item was used to assess perceived social support. This item read, “In times
of trouble, can you count on at least some of your family or friends?” Respondents
indicating that this was true for them “most of the time” were compared to respondents
indicating that they could count on family or friends “hardly ever/never” or only “some of
the time” (Van Dorn, Elbogen, Redlich, Swanson, Swartz, & Mustillo, 2006a). Time-
invariant covariates assessing race (whites were compared to non-whites), sex (males were
compared to females) and diagnosis (bipolar disorder and major depressive disorder with
psychotic features were compared to schizophrenia) were also included in all multivariable
models.
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For research questions one and two, barriers to PAD completion over a one year period
(baseline, six months and twelve months) were estimated with a Poisson model for repeated
measures with SAS v.9.1 (Diggle, Liang, & Zeger, 1994; Stokes, Davis, & Koch, 1995).
These models incorporate all available longitudinal data for each participant, and estimate
the net association of multiple fixed as well as time-varying predictors of reduced PAD
barriers. The models also adjust for lack of independence between observations for each
participant over time by using an autoregressive covariance structure, i.e., a matrix wherein
the correlation gradually declines between baseline and successive follow-up measures of
the dependent variable (PAD barriers). For research question three, a chi-square analysis
was used to assess differences in changes between baseline and 6 month barriers and rates of
PAD completion. Finally, for research question four, a logistic regression was used to assess
whether or not perceived barriers at 6 months predicted completion of PADs for those
assigned to the experimental condition, controlling for baseline barriers.
Results
Sample characteristics
At baseline, the average age of participants was 43 years (standard deviation=10.7 years).
The sample was 60% female, 40% white and only 12% were married or cohabiting. Twenty-
six percent of the sample had less than a high school education and only 24% of participants
worked for pay in the past month while 59% of participants were living independently at
baseline.
Regarding clinical characteristics, 57% of participants had a chart diagnosis of
schizophrenia or related psychotic disorder, 28% had bipolar disorder and 16% had
depression with psychotic features. The mean score on the Brief Psychiatric Rating Scale
(BPRS) was 33.0, with a standard deviation of 9.1, indicating a moderate level of
symptomatology. Finally, 35.3% of participants reported more than one outpatient visit
during the past month.
Research questions one and two
Bivariate differences in PAD barriers
At baseline there were no significant differences between the experimental and control
conditions on either of the two types of barriers (see Table 1). Both groups reported the most
substantial barriers to be those associated with the PAD documents themselves.
Approximately, three-quarters of the participants in both groups reported barriers related to
the PAD documents whereas one-third of participants in both groups stated that they
perceived barriers associated with external support for PADs. Throughout the course of the
study, however, the experimental group progressively reported fewer barriers than did the
control group.
F-PAD effects on barriers
Tables 2 (barriers associated with the PAD documents themselves) and 3 (barriers
associated with external support for PADs) display the results of the F-PAD intervention's
effect on reducing barriers to PAD completion. Each of the multivariable tables contains
three models. The first model shows results from the comparison between the experimental
and control conditions while the second model adds relevant covariates, including time and
sociodemographic, clinical and social support characteristics. The final model in each of the
tables adds the effect for the experimental-condition-by-time interaction.
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The first multivariable regression models in Tables 2 and 3 indicate significant differences
between the experimental and control conditions for both types of barriers: those associated
with the PAD documents (OR=0.83, p<0.01) and those associated with external support for
PADs (OR=0.73, p<0.01) over the one year study period.
Controlling for time and sociodemographic, clinical and social covariates did not change the
outcomes between the experimental and control conditions. In these second models, there
was a significant and negative main effect for time when assessing barriers related to the
PAD documents. (The effect of time for the barriers related to external support for PADs
was not significant.)
With regard to diagnoses, those with bipolar disorder were less likely to report barriers
related to the PAD documents than were those with schizophrenia. Those with depression
with psychotic features, however, were more likely than those with schizophrenia to report
these barriers. Considering other clinical variables, there was significant and positive main
effect for psychotic symptoms as measured by the BPRS; this significant and positive effect
was found for both types of barriers. Additionally, there were significant and negative main
effects for treatment satisfaction (barriers associated with the PAD documents) and working
alliance (for both barriers associated with the PAD documents and barriers associated with
external support for PADs). Finally, social support was a significant and negative predictor
of reporting barriers related to external support for PADs.
The third model for Tables 2 and 3 includes the effect for the experimental-condition-by-
time interaction. In these models, the experimental-condition-by-time interaction indicated
that those receiving the intervention were significantly less likely to report either of the two
types of barriers over the one-year study period than were those assigned to the control
group. Effects for the significant covariates from model two remained unchanged when
models included the intervention-by-time interaction.
Research questions three and four
PAD barriers and PAD completion
Briefly, results from the core outcome paper examining the effects of the PAD-facilitation
showed that 61% (n=146) of participants in the experimental condition completed a PAD;
this was in comparison to only 3% (n=7) of those in the control condition that completed a
PAD (Swanson et al., 2006a). While those prior results demonstrated that the facilitation
increased rates of PAD completion, the current results indicate that the intervention was able
to significantly reduce barriers over time for those in the experimental group compared to
those in the control group. However, the question remains as to whether or not these barriers
were indeed related to PAD completion. In order to address this issue we conducted two
additional analyses. The first analysis examined the PAD completion rate for those whose
barriers were reduced over time compared to those whose barriers increased over time. The
second analysis examined the ability of the barriers to predict PAD completion; both of
these analyses were conducted on those assigned to the experimental condition. (The ability
to conduct a similar analysis on the control condition was not possible given the low rate of
PAD completion in this group.)
For the former analysis two groups were created: (1) those whose barriers started and
remained at zero between baseline and 6 months in addition to those whose barriers
decreased between baseline and 6 months (e.g., started at 2 and went to 1 or 0; or started at 1
and went to 0) and (2) those whose barriers started and remained at either 1 or 2 between
baseline and 6 months in addition to those whose barriers increased between baseline and 6
months (e.g., started at 0 and went to 1 or 2; or started at 1 and went to 2). Differences in
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rates of PAD completion were then examined between these two groups for both types of
barriers (i.e., those related to the PAD documents and those related to external support for
PADs). Fifty three percent (n=100) and 68.8% (n=130) of participants had their barriers
remain at zero, or decrease, between baseline and 6 months for the barriers related to the
PAD documents and external support for PADs, respectively. This was in comparison to
47.1% (n=89) and 31.2% (n=59) of participants that had their barriers remain at one or two,
or increase, between baseline and 6 months for barriers related to the PAD documents and
external support for PADs, respectively.
When assessing barriers related to the PAD documents, those whose barriers remained at
zero or decreased between baseline and 6 months were significantly more likely to complete
a PAD than those whose barriers remained at one or two, or increased between baseline and
6 months (73.0% compared to 56.2%; p<0.05). When assessing barriers related to external
support for PADs, those whose barriers remained at zero or decreased between baseline and
6 months were significantly more likely to complete a PAD than those whose barriers
remained at one or two, or increased between baseline and 6 months (70.8% compared to
52.5%; p<0.05).
We next conducted a multivariable logistic regression examining the relationship between
one's 6 month barriers and PAD completion while controlling for one's baseline barriers.
This analysis indicated that both types of barriers had a negative effect on PAD completion.
Specifically, those reporting barriers related to the PAD documents were 41% less likely to
have completed a PAD (OR=0.59, p<0.05) while those reporting barriers related to external
support for PADs were 44% less likely to have completed a PAD (OR=0.56, p<0.05).
Discussion
This study examined (1) the ability of a facilitated intervention (F-PAD) to reduce perceived
barriers to PAD completion and (2) the relationship between these barriers and PAD
completion. Findings from the current study complement and expand upon earlier findings
indicating that a facilitated intervention increased the rate of PAD completion for persons
with severe mental illness randomly assigned to an experimental condition compared to
those assigned to a control condition. Specifically, 61% of participants in the facilitated
session completed an advance directive or authorized a proxy decision maker, compared
with only 3% of control group participants (Swanson et al., 2006a).
The present study yielded three findings of note. First, the intervention reduced individual
barriers related to PAD documents—i.e., not understanding the PAD and not knowing what
to write in the PAD. This result augments previous evidence from the same study showing
that the F-PAD intervention significantly improved the competence of cognitively-impaired
clients to write PADs and make treatment decisions within PADs (Elbogen et al., 2007).
Second, the intervention reduced barriers related to external support for PADs—i.e., not
having anyone to trust or fulfill the roles of a health care agent (HCA) and problems with
one's primary clinician. Third, reduction of these specific types of barriers appears to have
functioned as an important mechanism by which the intervention actually resulted in
completed PADs. These findings reinforce the effectiveness of the F-PAD intervention by
providing insight into how it works.
The intervention may also have had some effects beyond mere completion of a PAD. By
assisting the individual in selecting a person to serve as HCA, and addressing concerns
about the clinician, the F-PAD session may have positively affected participants' perceptions
of individuals around them. It is noteworthy that the intervention exerted a significant effect
on these external support variables, even controlling for the covariate effects of therapeutic
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alliance and social support. Those completing PADs may have done something more than
simply fill out the requisite paperwork; at least some of them may have had helpful
conversations with family, friends and clinicians about their past, current and desired forms
of treatment. Indeed, data from a separate, qualitative component of the study lends some
support for this explanation (Kim, Van Dorn, Scheyett, Elbogen, Swanson, Swartz, &
McDaniel, 2007).
However, the F-PAD intervention did not completely eliminate barriers to PAD completion,
and some people completed PADs despite persistent barriers. Some scholars have voiced
concerns that consumers may complete PADs without appropriate reflection and discussion
(Amering, Stastny, & Hopper, 2005). The current data suggest that people can complete
PADs without clearly understanding what these documents are for and how they work. It
seems likely that such PADs would be less often invoked and less effective in guiding
treatment. In future research it will be important to assess whether or not different models of
PAD facilitation, including a process that involves one's treatment team directly (e.g., akin
to joint crisis plans; cf., Henderson, Flood, Leese, Thornicroft, Sutherby, & Szmukler, 2004;
Henderson, Swanson, Szmukler, Thornicroft, & Zinkler, 2008), can more effectively reduce
barriers over time and also lead to beneficial implementation of PADs in practice.
The study has a potentially broader message about the importance of ongoing social and
therapeutic support for persons with severe mental illness. Specifically, social support in the
current research was a significant and negative predictor of barriers associated with external
support for PADs. Social support has also been shown to moderate the relationship between
perceived barriers to care and mandated treatment (Van Dorn et al., 2006a). Therefore,
better, or more positive, relationships with friends and family, as evidenced by the PAD
consumer-HCA agreement, might allow patients to avoid mandate-related barriers to
treatment. Consequently, by reducing these barriers, PADs may also reduce the need for
“leveraged” community treatment (i.e., treatment mandates related to housing,
representative payees, criminal justice or outpatient commitment; cf., Monahan, Redlich,
Swanson, Robbins, Appelbaum, Petrila, Steadman, Swartz, Angell, & McNiel, 2005;
Swanson, Tepper, Backlar, & Swartz, 2000). Additionally, if relationships with clinicians or
other formal service providers are improved, then long-term improvements in psychiatric
status and service utilization are more likely (Faccincani, Mignolli, & Platt, 1990; Shaw,
Patterson, Semple, Halpain, Koch, Harris, Grant, & Jeste, 2000). Further investigation
should address these potentially beneficial “secondary” outcomes related to PAD
facilitation, and examine how the perception of social support affects not only barriers to
PAD completion but also treatment engagement and personal autonomy.
Finally, these findings provide a starting point for the discussion of tailoring PAD
facilitations for persons with particular clinical characteristics, including different diagnoses.
The current results indicate that persons diagnosed with bipolar disorder were less likely to
report barriers associated with the PAD documents than were those with schizophrenia.
However, those with a diagnosis of depression with psychotic features were more likely than
those with schizophrenia to report these same barriers; these findings held when controlling
for psychotic symptoms. Given that research into PADs and PAD facilitations is still
developing it will be important to confirm or disconfirm these findings in future research, in
addition to better explicating reasons for these potential differences.
Consistent with the current findings, other recent research has indicated that those with a
psychotic diagnosis showed lower performance when being evaluated for competence to
make treatment decisions within PADs compared to those with other disorders (Elbogen et
al., 2007). It is possible that psychotic disorders impede one's understanding of PAD
documents, in addition to what content to include in the documents. However, it appears that
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a PAD facilitation can dampen some of these barriers. Still, a more nuanced understanding
of these issues is important if PAD interventions are to develop a stronger evidence-base;
thus ensuring that people with severe mental illness, regardless of diagnosis, achieve a
desired outcome with respect to PADs.
The main limitation of this study is that the benefits of the PAD facilitation may not
generalize to all persons with severe mental illness. Patients who were not engaged in
treatment or who refused consent to participate may have had different responses to the
facilitation, or may have articulated a more intractable set of barriers to PAD completion.
Also, we were unable to examine outcomes associated with non-F-PAD completed
documents (i.e., those completed by persons in the control group) as there were too few of
these types of documents completed in the randomized trial. However, future research will
want to assess whether or not the positive outcomes identified in this paper generalize to
consumer-completed documents.
In sum, we find evidence that a structured, facilitated intervention can effectively reduce
multiple barriers to PAD completion – barriers related to both the PAD documents (i.e.,
understanding and knowing what to write) and external support for PADs (i.e., having
someone to trust for the HCA function of PADs and improving relations with one's primary
clinician). Further, we find that barriers to PAD completion affect the likelihood of people
completing PADs. The current research adds to a growing coda of studies that are beginning
to find both short- and long-term benefits of PADs, and of PAD facilitation. In particular,
these findings indicate that to a large extent, the facilitated intervention (Swanson et al.,
2006b) worked by reducing these barriers to PAD completion. However, significant system-
level change is required before PADs achieve their potential and become an accepted part of
mental health treatment (Srebnik & Brodoff, 2003; Van Dorn et al., 2006b).
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Table 2
Multivariable GEE poisson regression model: Barriers associated with the PAD documents
Model 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Barriers: PAD documents
 Experimental group 0.83 (0.74– 0.94)** 0.81 (0.73– 0.91)*** 1.07 (0.90– 1.27)
Mediating variables
 Time 0.94 (0.91– 0.97)*** 0.37 (0.35– 0.38)***
 Diagnosis
  Schizophrenia [reference] - - - - - -
  Bipolar disorder 0.75 (0.63– 0.88)*** 0.75 (0.63– 0.88)***
  Depressive disorder w/psychotic features 1.16 (1.01– 1.32)** 1.16 (1.01– 1.32)**
 Male 1.05 (0.94– 1.18) 1.05 (0.94– 1.18)
 White 0.85 (0.75– 0.96)* 0.85 (0.75– 0.96)*
 Outpatient visits (more than 1) 1.00 (0.91– 1.09) 1.00 (0.91– 1.10)
 Treatment satisfaction (above median) 0.89 (0.80– 1.00)** 0.88 (0.79– 0.99)**
 Working alliance (above median) 0.92 (0.84– 1.01)† 0.92 (0.84– 1.01)†
 Social support 0.98 (0.90– 1.08) 0.98 (0.89– 1.08)
 Brief Psychiatric Rating Scale 1.01 (1.00– 1.01)* 1.01 (1.00– 1.01)*
Time by treatment interation
 Control group*time [reference] - - -
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Table 3
Multivariable GEE poisson regression model: External support for PADs
Model 1 Model 2 Model 3
OR 95% CI OR 95% CI OR 95% CI
Barriers: External support for PADs
 Experimental group 0.73 (0.60– 0.90)** 0.71 (0.59– 0.86)*** 1.14 (0.81– 1.60)
Mediating variables
 Time 1.05 (1.00– 1.11)† 0.42 (0.39– 0.45)***
 Diagnosis
  Schizophrenia [reference] - - - - - -
  Bipolar disorder 0.95 (0.74– 1.21) 0.95 (0.75– 1.22)
  Depressive disorder w/psychotic features 1.07 (0.85– 1.35) 1.07 (0.85– 1.35)
 Male 1.06 (0.88– 1.30) 1.07 (0.88– 1.30)
 White 1.05 (0.85– 1.30) 1.06 (0.86– 1.31)
 Outpatient visits (more than 1) 1.02 (0.87– 1.19) 1.02 (0.87– 1.19)
 Treatment satisfaction (above median) 0.87 (0.71– 1.07)† 0.86 (0.70– 1.05)†
 Working alliance (above median) 0.76 (0.65– 0.89)*** 0.76 (0.65– 0.90)***
 Social support 0.65 (0.55– 0.77)*** 0.65 (0.55– 0.76)***
 Brief Psychiatric Rating Scale 1.02 (1.01– 1.02)** 1.02 (1.01– 1.02)**
Time by treatment interation
 Control group*time [reference] - - -
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